Research
Energy balance
Semaglutide is available in two formulations: once-weekly subcutaneous and once-daily oral.
Practitioners can offer patients a choice between two formulations of semaglutide for weight management.
StrongSupportsmedium confidence
Currently, semaglutide is on the market in two formulations, the once-weekly subcutaneous (s.c.) semaglutide and once-daily oral semaglutide.
Why this rating
The claim is based on a review of the drug's market availability.
Source
Semaglutide and obesity: beyond the nutritional and lifestyle intervention?
Livia Basile et al. · Minerva Endocrinology · 2024
DOI 10.23736/s2724-6507.23.04103-9
reviewCited 7×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →